Evidence map›Paper›PMID 19125180›Full record

ArticleMediators of inflammation2008

Peripheral mononuclear cell resistin mRNA expression is increased in type 2 diabetic women.

Panayoula C Tsiotra, Constantine Tsigos, Eleni Anastasiou, Eleni Yfanti, Eleni Boutati, Emmanouil Souvatzoglou, Ioannis Kyrou, Sotirios A Raptis

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Review
  3. Characterization and Treatment of Inflammation and Insulin Resistance in Obese Adipose Tissue.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Review
  4. Association ofDiabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Resistin in rodents and humans.Diabetes & metabolism journal · 2013
    Article
  13. Review
  14. Article
  15. Article
  16. Serum CCL 18 Levels in Women with Polycystic Ovarian Syndrome.Indian journal of endocrinology and metabolism
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Panayoula C TsiotraDivision of Basic Sciences, Hellenic National Center for the Research, Prevention and Treatment of Diabetes Mellitus and Its Complications (HNDC), Athens, Greece. ytsiotra@hndc.gr
Constantine Tsigos
Eleni Anastasiou
Eleni Yfanti
Eleni Boutati
Emmanouil Souvatzoglou
Ioannis Kyrou
Sotirios A Raptis
Hellenic Center for Disease Control & Prevention · GRAlexandra Hospital · GRUniversity General Hospital Attikon · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resistin has been shown to cause insulin resistance and to impair glucose tolerance in rodents, but in humans its physiological role still remains elusive. The aim of this study was to examine whether resistin mRNA expression in human peripheral mononuclear cells (PBMCs) and its corresponding plasma levels are altered in type 2 diabetes. Resistin mRNA levels were easily detectable in human PBMC, and found to be higher in DM2 compared to healthy women (P = .05). Similarly, mononuclear mRNA levels of the proinflammatory cytokines IL-1beta, TNF-alpha, and IL-6 were all significantly higher in DM2 compared to control women (P < .001). The corresponding plasma resistin levels were slightly, but not significantly, increased in DM2 women (P = .051), and overall, they correlated significantly with BMI (r = 0.406, P = .010) and waist circumference (r = 0.516, P = .003), but not with fasting insulin levels or HOMA-IR. Resistin mRNA expression is increased in PBMC from DM2 women, together with increased expression of the inflammatory cytokines IL-1beta, TNF-alpha, and IL-6, independent of obesity. These results suggest that resistin and cytokines might contribute to the low-grade inflammation and the increased atherogenic risk observed in these patients.

Indexed as

ResistinAdultAnimalsDiabetes Mellitus, Type 2FemaleHumansInterleukin-1betaInterleukin-6Leukocytes, MononuclearMiddle AgedRNA, MessengerTumor Necrosis Factor-alphaYoung AdultInterleukin-1betaInterleukin-6ResistinRNA, MessengerTumor Necrosis Factor-alpha

Identifiers

PMID19125180
PMCPMC2606019
OpenAlexW2081323278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.